ArticleAnimal nutrition (Zhongguo xu mu shou yi xue hui)2026
Impact of fraction size on the efficacy of xylo-oligosaccharides in broiler chicken diets.
Article in Animal nutrition (Zhongguo xu mu shou yi xue hui), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Numerous studies have reported the beneficial effects of supplemental xylo-oligosaccharides (XOS) on broiler performance and nutrient utilization. These effects are attributed to their prebiotic action, directly fueling beneficial bacterial species, and their ability to stimulate fibre-degrading bacteria in the gastrointestinal tract. Commercial XOS products typically contain mixtures with varying degrees of polymerisation (DP), ranging from xylobiose (X2) to xylohexaose (X6). This study aimed to determine the optimum DP range of XOS for broiler chickens. Two trials were conducted using 0 d-old Cobb 500 broilers (300 per trial, 60 birds per treatment, initial body weight 45.80 ± 0.15 g) fed wheat-based diets over 35-d period as three phases (starter d 0-12, grower d 12-23, and finisher d 23-35). In both trials, birds were fed one of five XOS treatments (150 g/tonne); no XOS (control), low-DP XOS, medium-DP XOS, high-DP XOS, or a standard commercial XOS mixture. In Trial 1, the XOS treatments were fed without xylanase, and in Trial 2 the XOS treatments were fed with xylanase (16,000 birchwood xylanase units [BXU]/kg). In Trial 1, birds fed the high-DP XOS had significantly lower feed conversion ratio corrected for mortality (cFCR) at d 0 to 35 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.